David Rescott

Stock Analyst at Baird

(4.7)
# 1214
Out of 5,448 analysts
80
Total ratings
Success rate
Average return
11 Stocks
Name Action PT Current % Upside Ratings Updated
MDT Medtronic
Maintains: Neutral
94 96
91.11 5.37% 7 Aug 20, 2025
PEN Penumbra
Maintains: Strong Buy
300 310
251.38 23.32% 31 Jul 30, 2025
EW Edwards Lifesciences
Maintains: Neutral
78 79
81.19 -2.7% 5 Jul 25, 2025
BSX Boston Scientific
Maintains: Outperform
117 123
105.22 16.9% 8 Jul 24, 2025
HAE Haemonetics
Initiates Coverage On: Outperform
87
54.02 61.05% 1 Jun 26, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
55 61
52.86 15.4% 4 May 8, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
111 110
86.63 26.98% 3 Apr 25, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
600 575
469.88 22.37% 3 Apr 23, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
81 80
79.97 0.04% 4 Jan 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
73 71
n/a n/a 8 Jan 16, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
25 26
15.64 66.24% 6 Dec 22, 2023